FDA Panel Endorses Telmisartan as Alternative to Ramipril to Reduce Cardiovascular Risk http://tinyurl.com/o252tn
6:21 PM - 29 Jul 2009
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.